Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions S Nasrin, CJW Watson, YX Perez-Paramo, P Lazarus Drug Metabolism and Disposition 49 (12), 1070-1080, 2021 | 82 | 2021 |
A new gene expression signature for triple-negative breast cancer using frozen fresh tissue before neoadjuvant chemotherapy SK Santuario-Facio, S Cardona-Huerta, YX Perez-Paramo, V Trevino, ... Molecular Medicine 23, 101-111, 2017 | 53 | 2017 |
Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF … MEG Naranjo, F Rodrigues-Soares, EM Penas-Lledo, E Tarazona-Santos, ... Omics: a journal of integrative biology 22 (9), 575-588, 2018 | 42 | 2018 |
Genomic Ancestry, CYP2D6, CYP2C9, and CYP2C19 Among Latin Americans F Rodrigues‐Soares, EM Peñas‐Lledó, E Tarazona‐Santos, ... Clinical Pharmacology & Therapeutics 107 (1), 257-268, 2020 | 33 | 2020 |
Losartan Hydroxylation Phenotype in an Ecuadorian Population: Influence of CYP2C9 Genetic Polymorphism, Habits and Gender P Dorado, LJ Beltran, E Machin, EM Penas-LLedo, E Teran, A LLerena, ... Pharmacogenomics 13 (15), 1711-1717, 2012 | 27 | 2012 |
CYP2D6 -1584C>G Promoter Polymorphism and Debrisoquine Ultrarapid Hydroxylation in Healthy Volunteers A LLerena, P Dorado, R Ramírez, LR Calzadilla, E Penas-LLedo, ... Pharmacogenomics 14 (16), 1973-1977, 2013 | 23 | 2013 |
Nicotine-N′-Oxidation by Flavin Monooxygenase Enzymes YX Perez-Paramo, G Chen, JH Ashmore, CJW Watson, S Nasrin, ... Cancer Epidemiology, Biomarkers & Prevention 28 (2), 311-320, 2019 | 19 | 2019 |
Interethnic Relationships of CYP2D6 Variants in Native and Mestizo Populations Sharing the Same Ecosystem YX Perez-Paramo, F Hernandez-Cabrera, P Dorado, A Llerena, ... Pharmacogenomics 16 (7), 703-712, 2015 | 17 | 2015 |
Pharmacogenetics in Latin American populations: regulatory aspects, application to herbal medicine, cardiovascular and psychiatric disorders I Rodeiro, D Remírez-Figueredo, M García-Mesa, P Dorado, A LLerena, ... Walter de Gruyter 27 (1), 57-60, 2012 | 16 | 2012 |
Pharmacogenetics factors influencing smoking cessation success; the importance of nicotine metabolism YX Perez-Paramo, P Lazarus Expert opinion on drug metabolism & toxicology 17 (3), 333-349, 2021 | 14 | 2021 |
Development of a HPLC method for the determination of losartan urinary metabolic ratio to be used for the determination of CYP2C9 hydroxylation phenotypes P Dorado, E Machín, F de Andrés, MEG Naranjo, EM Peñas-Lledó, ... Drug Metabolism and Drug Interactions 27 (4), 217-223, 2012 | 14 | 2012 |
Association of CYP2C19* 2 polymorphism with clopidogrel resistance among patients with high cardiovascular risk in Northeastern Mexico FR Cedillo-Salazar, L Martínez-Jacobo, YX Pérez-Páramo, ... Archivos de cardiología de México 89 (4), 324-329, 2019 | 10 | 2019 |
Genetic variants in CYP2A6 and UGT1A9 genes associated with urinary nicotine metabolites in young Mexican smokers G Borrego-Soto, YX Perez-Paramo, G Chen, SK Santuario-Facio, ... The Pharmacogenomics Journal 20 (4), 586-594, 2020 | 7 | 2020 |
Exome sequencing reveals three homozygous missense variants in SNRPA in two sisters with syndromic intellectual disability MM Rangel‐Sosa, LE Figuera‐Villanueva, IA González‐Ramos, ... Clinical Genetics 93 (6), 1229-1233, 2018 | 6 | 2018 |
CYP2C19 plays a major role in the hepatic N-oxidation of cotinine YX Perez-Paramo, CJW Watson, G Chen, P Lazarus Drug Metabolism and Disposition 51 (1), 29-37, 2023 | 4 | 2023 |
Development of an LC-MS/MS method to measure sphingolipids in CSF from patients with multiple sclerosis YX Perez-Paramo, D Dufield, R Veeramachaneni, E Parkhurst, C Harp, ... Molecular Pharmacology 105 (3), 121-130, 2024 | 2 | 2024 |
Impact of genetic variants in the nicotine metabolism pathway on nicotine metabolite levels in smokers YX Perez-Paramo, CJW Watson, G Chen, CE Thomas, J Adams-Haduch, ... Cancer Epidemiology, Biomarkers & Prevention 32 (1), 54-65, 2023 | 2 | 2023 |
NUSAP1 and PCLAF (KIA0101) Downregulation by Neoadjuvant Therapy is Associated with Better Therapeutic Outcomes and Survival in Breast Cancer GI Magallanes-Garza, SK Santuario-Facio, S Lira-Albarrán, ... Journal of Oncology 2022 (1), 6001947, 2022 | 2 | 2022 |
Cytochrome P450 Enzyme Contributions to the N‐oxide Detoxification Pathway of Tobacco‐Specific Nitrosamines; a Possible Role in Tobacco‐Related Cancer Risk YX Perez‐Paramo, CJW Watson, Z Xia, G Chen, P Lazarus The FASEB Journal 33 (S1), 508.8-508.8, 2019 | 2 | 2019 |
CYP2D6 in amerindians from southern mexico: low variability and higher frequency of functional alleles YX Perez-Paramo, F Hernandez-Cabrera, A Rojas-Martinez, ... Drug Metabolism and Personalized Therapy 30 (4), 231-238, 2015 | 2 | 2015 |